FirstSun Capital Bancorp is set to report its Q4 2025 earnings after the market close on January 26, 2026, with analysts expecting year-on-year revenue growth and earnings of US$0.85 per share.
ELPIS II top-line trial results are anticipated in the third quarter of 2026Laromestrocel Biological License Application (BLA) submission for full traditional approval for HLHS anticipated if ELPIS II ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results